Antibiotics for neonatal sepsis in low-income and middle-income countries—where to go from here?

Luregn J. Schlapbach; Annemarie van Rossum; Enitan D. Carrol

doi:10.1016/S1473-3099(21)00199-7

Antibiotics for neonatal sepsis in low-income and middle-income countries—where to go from here?

Luregn J. Schlapbach
, Annemarie van Rossum
, Enitan D. Carrol

Pediatrics

University of Queensland
University of Zurich
University of Liverpool

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

5 Citations (Scopus)

6 Downloads (Pure)

Original language	English
Pages (from-to)	1617-1618
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	21
Issue number	12
DOIs	https://doi.org/10.1016/S1473-3099(21)00199-7
Publication status	Published - 1 Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-04-54-08-A

Access to Document

10.1016/S1473-3099(21)00199-7Licence: Unspecified

Schlapbach_Lancet Inf Dis_2021Accepted author manuscript, 485 KBLicence: CC BY-NC-ND

Cite this

@article{12605b1856d3492381a6beb020f67dcc,

title = "Antibiotics for neonatal sepsis in low-income and middle-income countries—where to go from here?",

author = "Schlapbach, \{Luregn J.\} and \{van Rossum\}, Annemarie and Carrol, \{Enitan D.\}",

year = "2021",

month = dec,

day = "1",

doi = "10.1016/S1473-3099(21)00199-7",

language = "English",

volume = "21",

pages = "1617--1618",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",